Showing results (301-310 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|June 9, 2015
PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21Fei-Ran Gong, Meng-Yao Wu, Meng Shen, et al.
Oncotarget|June 9, 2015
MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of boneTing Wang, Huabin Yin, Jing Wang, et al.
Oncotarget|June 9, 2015
Targeting the Hedgehog signaling pathway in cancer: beyond SmoothenedAnnelies Gonnissen, Sofie Isebaert, Karin Haustermans
Oncotarget|June 9, 2015
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapySheng Chen, Liang Huang, Can-Ming Chen, et al.
Oncotarget|June 9, 2015
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese womenSumie Kato, Lorena Abarzua-Catalan, César Trigo, et al.
Oncotarget|June 11, 2015
Cripto-1 as a novel therapeutic target for triple negative breast cancerNadia P Castro, Natalie D Fedorova-Abrams, Anand S Merchant, et al.
Oncotarget|June 10, 2015
Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regionsJuan Wang, Guomu Liu, Qiongshu Li, et al.
Oncotarget|June 10, 2015
siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cellsChunyan Li, Zhenzhen Liu, Fang Yang, et al.
Oncotarget|June 6, 2015
AS1411-conjugated gold nanospheres and their potential for breast cancer therapyMohammad T Malik, Martin G O'Toole, Lavona K Casson, et al.
Oncotarget|June 8, 2015
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapyHua-chuan Zheng, Jing Li, Dao-fu Shen, et al.
Pageof 2,516